UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ~~ISSUER~~ISSUERPURSUANT TO RULE 13A-16 OR 15D-16 UNDERTHE SECURITIES EXCHANGE ACT OF 1934

~~PURSUANT~~For TOthe ~~RULE~~month ~~13A-16~~of ORJanuary ~~15D-16~~ 2026

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2025

Commission File Number: 001-40010

Pharvaris N.V.

(Translation of registrant’s name into English)

Emmy Noetherweg 2

2333 BK Leiden

The Netherlands(Address of principal executive office)

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

PHARVARIS N.V.

On ~~December 3~~January 12, ~~2025~~2026, Pharvaris N.V. (the “Company”) issued a press release ~~announcing positive topline data from the RAPIDe-3 pivotal study~~. AThe ~~copy of the~~ press release is attached ~~hereto~~ as Exhibit 99.1. ~~Exhibit~~hereto ~~99.1~~and ~~shall~~is ~~not~~incorporated beby ~~deemed~~reference ~~“filed”~~herein. ~~for~~Also ~~purposes~~on ofJanuary ~~Section 18~~12, of2026, the ~~Securities~~Company ~~Exchange~~made ~~Act~~available ofan ~~1934~~investor ~~(the~~presentation ~~“Exchange~~on ~~Act”)~~its orwebsite. ~~otherwise subject~~A tocopy ~~the liabilities~~ of ~~that section, nor shall it be deemed incorporated by reference in any filing under~~ the ~~Securities~~investor ~~Act~~presentation ofis ~~1933,~~attached hereto as ~~amended,~~Exhibit ~~or the Exchange Act~~99. 2.

~~EXHIBIT~~Exhibit ~~INDEX~~99.1 to this Report on Form 6-K shall be deemed to be incorporated by reference into the registration statements on Form F-3 (Registration Number 333-273757, 333-277705 and 333-278650) and Form S-8 (Registration Number 333-252897). Exhibit 99.2 to this Report on Form 6-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act.

ExhibitNo.		Description
99.1		Press Release, dated December 3, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	PHARVARIS N.V.		~~PHARVARIS N.V.~~
Date: December 3, 2025			By:	/s/ Berndt Modig
Date: January 12, 2026	By:	/s/ Berndt Modig
	Name:	Berndt Modig	~~Name:~~	~~Berndt Modig~~
	Title:	Chief Executive Officer	~~Title:~~	~~Chief Executive Officer~~

EXHIBIT INDEX


Exhibit No.		Description
99.1		Press release, dated January 12, 2026.
99.2		Investor Presentation, dated January 12, 2026.

Filing Compare · Pharvaris N.V.